Reply To: Traders Market Weekly: Powell Testifies

#60211
Truman
Participant

Chinook Therapeutics (KDNY 39.52, +15.51, +64.2%): to be acquired by Novartis (NVS) for $40.00 per share upfront plus contingent value right of up to $4.00 per share